BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35781514)

  • 1. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
    Mushi MF; Olum R; Bongomin F
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
    Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
    J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
    Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A; Abebaw Y
    BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
    Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
    BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
    Dunaiski CM; Kock MM; Chan WY; Ismail A; Peters RPH
    Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38308518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
    Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
    Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
    Brandão LDS; Boniek D; Resende Stoianoff MA; da Mata FMR; de Azevedo PRM; Fernandes JV; Andrade VS
    Lett Appl Microbiol; 2018 Sep; 67(3):285-291. PubMed ID: 29908032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
    Chen Z; Jin J; Chen H; Chen Y; Feng S
    Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
    Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
    BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.